Tracers / [86Y]pepa-pic2-C-Hex-KuE

[86Y]pepa-pic2-C-Hex-KuE

Radionuclide
Y-86 t½ 884.4 min
Modality
Therapy
Production route
Stage
Reported once
Syntheses indexed
1

What it is

Compound class
PSMA-targeting urea-based small molecule (C-Hex-KuE) conjugated to pepa-pic2 chelator
Target / mechanism
Prostate-specific membrane antigen (PSMA) PMID 41324598
Clinical application
Theranostic pair

Regulatory status

FDA
EMA (centralised)
Other approvals
Brand names

Clinical use

Typical injected activity
Uptake time

Reported in the literature. Not a dosing recommendation.

Published syntheses

ModuleCassettePurificationYield %RCP %Precursor / supplierSource
Manual synthesisnone>98%pepa-pic2-C-Hex-KuE41324598
2025 J Am Chem Soc
Radiolabeling to afford [86Y]­Y-pepa-pic2-C-hex-KuE was performed under conditions similar to those used for the nontargeted chelators evaluated in the naïve biodistribution studies — the resulting complex was obtained with a high radiochemical yield

Need this precursor?We can point you to suppliers for [86Y]pepa-pic2-C-Hex-KuE, or handle the enquiry for you.

Get in touch

Notes

Added at stage 22: promoted from 'Reported once' (single-article, no diagnostic pair at discovery) because a full-text synthesis with extracted data exists in parsed-therapy.xlsx -- PMID(s): 41324598. Target/mechanism, clinical application, indications, approval and precursor fields still need per-agent research and are intentionally left empty. Compound class inferred from precursor name (not stated outright) -- PMID 41324598: 'pepa-pic2-C-hex-KuE'.